Skip to content

APOTHEEK ROOSENS: what changed

BE 0461.662.491NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€44,659
2024 · €63,769-€19,110
Equity
€254,888
2024 · €254,229+€659
Cash
€202,694
2024 · €13,164+€189,530
Balance sheet total
€1.2m
2024 · €1.1m+€83,347

Largest movements

2024 to 2025
Assets
  • Cash +€189,530

    up €189,530 (+1,440%), from €13,164 to €202,694

    mainly Trade debts (+€262,390) and Receivables within one year (+€61,973)

  • Receivables within one year -€61,973

    down €61,973 (-23.4%), from €265,154 to €203,181

    of which Trade receivables: -€52,907

  • Stocks and contracts -€35,982

    down €35,982 (-15.2%), from €236,796 to €200,814

  • Tangible fixed assets -€19,411

    down €19,411 (-3.4%), from €579,422 to €560,011

    of which Land and buildings: -€20,500

Equity and liabilities
  • Trade debts +€262,390

    up €262,390 (+69.9%), from €375,282 to €637,672

  • Current portion of long-term debt -€135,637

    down €135,637 (-85.3%), from €158,970 to €23,333

  • Debts after one year -€23,333

    down €23,333 (-11.1%), from €210,000 to €186,667

  • Other debts -€22,605

    down €22,605 (-25.5%), from €88,694 to €66,089

Income statement
  • Staff costs +€14,918

    up €14,918 (+7.5%), from €199,811 to €214,729

  • Gross operating margin -€11,772

    down €11,772 (-3.7%), from €319,044 to €307,272

  • Financial charges -€8,185

    down €8,185 (-36.6%), from €22,355 to €14,169

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €63,769
Gross operating margin -€11,772
Staff costs -€14,918
Depreciation +€30
Other operating charges -€112
Financial income -€184
Financial charges +€8,185
Taxes -€339
Result 2025 €44,659
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€401,457
Investment -€8,957
Financing -€202,970
Cash 2024 €13,164
Net result for the year +€44,659
Depreciation +€26,439
Stocks and contracts +€35,982
Receivables within one year +€61,973
Deferred charges and accrued income -€9,254
Trade debts +€262,390
Tax, wage and social debts +€2,504
Other debts -€22,605
Accrued charges and deferred income -€631
Investment in fixed assets (net) -€8,957
Debts after one year -€23,333
Current portion of long-term debt -€135,637
Contributions, distributions and other -€44,000
Cash 2025 €202,694
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,118,856 €1,202,203 +€83,347 +7.4%
Fixed assets 21/28 €579,422 €561,941 -€17,482 -3.0%
Intangible fixed assets 21 - €1,929 +€1,929
Tangible fixed assets 22/27 €579,422 €560,011 -€19,411 -3.4%
Land and buildings 22 €573,162 €552,662 -€20,500 -3.6%
Plant, machinery and equipment 23 €6,260 €7,349 +€1,089 +17.4%
Current assets 29/58 €539,433 €640,262 +€100,829 +18.7%
Stocks and contracts in progress 3 €236,796 €200,814 -€35,982 -15.2%
Stocks 30/36 €236,796 €200,814 -€35,982 -15.2%
Amounts receivable within one year 40/41 €265,154 €203,181 -€61,973 -23.4%
Trade receivables 40 €254,325 €201,418 -€52,907 -20.8%
Other amounts receivable 41 €10,829 €1,764 -€9,066 -83.7%
Cash at bank and in hand 54/58 €13,164 €202,694 +€189,530 +1,440%
Deferred charges and accrued income 490/1 €24,319 €33,573 +€9,254 +38.1%
Total equity and liabilities 10/49 €1,118,856 €1,202,203 +€83,347 +7.4%
Equity 10/15 €254,229 €254,888 +€659 +0.3%
Contributions 10/11 €62,000 €62,000 = 0.0%
Reserves 13 €192,229 €192,888 +€659 +0.3%
Distributable reserves 133 €192,229 €192,888 +€659 +0.3%
Amounts payable 17/49 €864,627 €947,315 +€82,688 +9.6%
Amounts payable after more than one year 17 €210,000 €186,667 -€23,333 -11.1%
Financial debts 170/4 €210,000 €186,667 -€23,333 -11.1%
Amounts payable within one year 42/48 €650,769 €757,421 +€106,653 +16.4%
Current portion of amounts payable after more than one year 42 €158,970 €23,333 -€135,637 -85.3%
Trade debts 44 €375,282 €637,672 +€262,390 +69.9%
Suppliers 440/4 €375,282 €637,672 +€262,390 +69.9%
Taxes, remuneration and social security 45 €27,822 €30,327 +€2,504 +9.0%
Taxes 450/3 €2,874 €4,209 +€1,335 +46.4%
Remuneration and social security 454/9 €24,948 €26,117 +€1,169 +4.7%
Other amounts payable 47/48 €88,694 €66,089 -€22,605 -25.5%
Accrued charges and deferred income 492/3 €3,858 €3,227 -€631 -16.4%
Remuneration, social security and pensions 62 €199,811 €214,729 +€14,918 +7.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €26,469 €26,439 -€30 -0.1%
Other operating charges 640/8 €3,565 €3,677 +€112 +3.1%
Gross operating margin 9900 €319,044 €307,272 -€11,772 -3.7%
Operating profit (loss) 9901 €89,199 €62,426 -€26,773 -30.0%
Financial income 75/76B €263 €79 -€184 -69.9%
Recurring financial income 75 €263 €79 -€184 -69.9%
Financial charges 65/66B €22,355 €14,169 -€8,185 -36.6%
Recurring financial charges 65 €22,355 €14,169 -€8,185 -36.6%
Profit (loss) for the period before taxes 9903 €67,108 €48,336 -€18,772 -28.0%
Income taxes 67/77 €3,339 €3,678 +€339 +10.1%
Profit (loss) for the period 9904 €63,769 €44,659 -€19,110 -30.0%
Profit (loss) for the period to be appropriated 9905 €63,769 €44,659 -€19,110 -30.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€296,883 to €365,044

Midpoint €325,283 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €252,958
Capitalised earnings €340,807 to €477,130
Indication €296,883 to €365,044

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€254,888
Intangible fixed assets (21)
-€1,929
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€252,958

Capitalised earnings

net result for the year (9904)
2025
€44,659
2024
€63,769
2023
€34,712
2022
€38,435
2021
€879
Average result
€47,713
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€340,807 / €397,608 / €477,130

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.